Neuronetics (STIM) Cash from Investing Activities Growth (3y) (2020 - 2026)
Neuronetics (STIM) Cash from Investing Activities Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.11 Bn | 194.51 Bn | 7.27 Bn | 17.83% |
| 2 | Stryker | 129.85 Bn | 126.37 Bn | 4.50 Bn | -6.23% |
| 3 | Medtronic | 119.93 Bn | 110.71 Bn | 6.41 Bn | -24.52% |
| 4 | Boston Scientific | 74.18 Bn | 73.64 Bn | 3.85 Bn | -32.54% |
| 5 | Edwards Lifesciences | 52.54 Bn | 48.29 Bn | 1.35 Bn | -68.12% |
| 6 | Dexcom | 34.76 Bn | 32.81 Bn | 830.00 Mn | 37.39% |
| 7 | GE HealthCare Technologies | 34.25 Bn | 32.14 Bn | 2.18 Bn | -11.04% |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn | 19.58% |
| 9 | Steris | 23.29 Bn | 22.80 Bn | 684.20 Mn | -17.67% |
| 10 | Neuronetics | 225.60 Mn | 206.17 Mn | 21.22 Mn | 13.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.40% |
| Mar 31, 2026 | 2.05% |
| Dec 31, 2025 | 24.56% |
| Sep 30, 2025 | -26.25% |
| Jun 30, 2025 | 36.10% |
| Mar 31, 2025 | 41.14% |
| Dec 31, 2024 | -43.68% |
| Sep 30, 2024 | 26.03% |
| Jun 30, 2024 | 34.98% |
| Mar 31, 2024 | 28.07% |
| Dec 31, 2023 | -69.80% |
| Sep 30, 2023 | 35.79% |
| Jun 30, 2023 | -43.34% |
| Mar 31, 2023 | 11.72% |
| Dec 31, 2022 | -11.90% |
| Sep 30, 2022 | 451.35% |
| Jun 30, 2022 | -98.24% |
| Mar 31, 2022 | -57.67% |
| Dec 31, 2021 | -30.43% |
| Sep 30, 2021 | -286.83% |